Ilaria Ferlenghi

Company: GlaxoSmithKline

Job title: Associate Director



Harnessing a Hybrid Approach Including X-Ray Crystallography, NMR, Cryo-EM, HDX, & Machine Learning to Accelerate the Discovery & Development of Vaccines 10:45 am

  • Combining and supporting structure-based vaccine identification, characterization and design with a combination of methods across discovery and development
  • Utilising machine learning to accelerate the identification of new vaccine using 3D protein structure information

day: Day 2

Panel Discussion: Debating the Challenges & Opportunities of the Structural Techniques Toolbox to Overcome Hurdles & Optimize Structure Based-Drug Design 1:30 pm

  • Dissecting the practical strengths and weaknesses of NMR, X-Ray crystallography, Cryo-EM, and Cryo-ET in current drug design projects
  • Proposing innovative strategies to overcome challenges and synergize and integrate techniques

day: Day 1

Ilaria Ferlenghi